ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,915Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 2170

$1.61M Total Retail Price of All Prescriptions

Rank: 17 out of 2170

765 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 765 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

22% of this provider’s 765 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 22,859 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 1,030 590 S3 1 7
FUROSEMIDE 1,016 902 2 6
OMEPRAZOLE 942 765 3 2
LISINOPRIL 799 668 4 3
SIMVASTATIN 737 588 5 1
LEVOTHYROXINE SODIUM 724 673 6 5
AMLODIPINE BESYLATE 639 552 7 4
METOPROLOL TARTRATE 568 517 8 10
ZOLPIDEM TARTRATE 489 326 9 17
METFORMIN HCL 453 345 10 8
WARFARIN SODIUM 427 384 11 15
TRAMADOL HCL 413 368 12 18
MIRTAZAPINE 392 367 13 46
PRAVASTATIN SODIUM 383 361 14 11
SERTRALINE HCL 372 327 15 25
JANTOVEN 355 355 16 104
MELOXICAM 347 233 17 28
DONEPEZIL HCL 344 332 18 32
POTASSIUM CHLORIDE 342 327 19 16
PANTOPRAZOLE SODIUM 310 277 20 39
ATORVASTATIN CALCIUM 295 214 21 12
CITALOPRAM HBR 271 223 22 19
NAMENDA 268 256 23 48
CLOPIDOGREL 266 235 24 37
CARVEDILOL 265 238 25 26
ALLOPURINOL 249 181 26 29
GABAPENTIN 244 189 27 14
LANTUS 237 227 28 51
POLYETHYLENE GLYCOL 3350 233 233 29 63
NEXIUM 219 180 30 22
CRESTOR 217 156 31 24
LYRICA 204 123 32 90
LISINOPRIL-HYDROCHLOROTHIAZIDE 197 181 33 20
METOPROLOL SUCCINATE 177 153 34 13
AMOXICILLIN 172 122 35 114
HYDROCHLOROTHIAZIDE 171 130 36 9
LOSARTAN POTASSIUM 171 168 36 21
EXELON 170 170 38 119
ALBUTEROL SULFATE 169 167 39 167
FLUOXETINE HCL 168 115 40 59
ESCITALOPRAM OXALATE 167 144 41 75
CYMBALTA 159 85 42 44
LANTUS SOLOSTAR 158 94 43 79
NOVOLOG 157 148 44 98
PLAVIX 153 143 45 58
RANITIDINE HCL 153 137 45 40
DIOVAN 150 116 47 53
PREDNISONE 148 130 48 41
ROPINIROLE HCL 145 104 49 92
SYNTHROID 137 105 50 27
TAMSULOSIN HCL 135 135 51 33
DILTIAZEM 24HR CD 134 134 52 82
SPIRIVA 133 107 53 49
KLOR-CON M20 123 116 54 68
ALENDRONATE SODIUM 118 102 55 36
ISOSORBIDE MONONITRATE ER 116 114 56 50
CYCLOBENZAPRINE HCL 116 56 R 56 52
CLONIDINE HCL 114 88 58 54
ADVAIR DISKUS 114 75 58 45
IPRATROPIUM BROMIDE 111 110 60 239
CARBIDOPA-LEVODOPA 110 90 61 110
DIGOXIN 109 105 62 72
SPIRONOLACTONE 109 74 62 71
PROMETHAZINE HCL 109 40 R 62 70
TRAZODONE HCL 109 81 62 38
FLUTICASONE PROPIONATE 107 99 66 30
CEFDINIR 105 81 67 192
PAROXETINE HCL 103 86 68 65
PROAIR HFA 100 66 69 43
VERAPAMIL ER 99 70 70 94
AVELOX 98 80 71 271
QUETIAPINE FUMARATE 98 80 71 88
OXYCODONE-ACETAMINOPHEN 97 67 S2 73 60
MUPIROCIN 93 86 74 177
AMITRIPTYLINE HCL 92 57 R 75 61
CIPROFLOXACIN HCL 91 75 76 69
KLOR-CON M10 86 58 77 132
TIZANIDINE HCL 86 33 77 123
VYTORIN 83 45 79 179
LEVOXYL 83 78 79 115
AZITHROMYCIN 82 54 81 47
FENTANYL 79 52 S2 82 87
PEN NEEDLE 79 53 82 141
VENTOLIN HFA 78 49 84 102
CELEBREX 77 76 85 89
DOXAZOSIN MESYLATE 76 62 86 93
RISPERIDONE 75 42 87 73
OXYBUTYNIN CHLORIDE ER 74 49 88 148
ATENOLOL 74 65 88 23
OXYCONTIN 74 31 S2 88 146
LEVOFLOXACIN 72 63 91 99
DILTIAZEM ER 72 72 91 133
SULFAMETHOXAZOLE-TRIMETHOPRIM 70 60 93 95
METOCLOPRAMIDE HCL 69 63 94 127
TRIAMCINOLONE ACETONIDE 69 68 94 128
MECLIZINE HCL 69 62 94 134
RESTASIS 68 68 97 233
LOVAZA 68 50 97 178
FAMOTIDINE 68 57 97 96
OXYCODONE HCL 67 51 S2 100 56
NITROFURANTOIN MONO-MACRO 67 63 100 196
GLIMEPIRIDE 66 53 102 31
CARISOPRODOL 65 25 R 103 111
TRICOR 65 45 103 130
OXYCODONE HCL-ACETAMINOPHEN 64 12 S2 105 74
DILANTIN 64 64 105 223
NASONEX 63 42 107 285
ABILIFY 62 43 108 159
TRAVATAN Z 60 60 109 181
CLOTRIMAZOLE-BETAMETHASONE 60 31 109 174
LANSOPRAZOLE 59 46 111 165
FENOFIBRATE 58 57 112 57
PHENYTOIN SODIUM EXTENDED 58 45 112 142
LATANOPROST 56 56 114 194
HALOPERIDOL 54 44 115 176
OXYBUTYNIN CHLORIDE 53 50 116 164
RAMIPRIL 52 35 117 77
TRAMADOL HCL-ACETAMINOPHEN 51 22 118 180
LIPITOR 50 38 119 83
DIOVAN HCT 50 44 119 76
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.